Swedish Orphan Biovit Ord
(BIOVF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2018 | |
| Sales | 242,358 |
| Cost of Goods | 68,117 |
| Gross Profit | 174,241 |
| Operating Expenses | 92,914 |
| Operating Income | 81,444 |
| Other Income | 247 |
| Pre-tax Income | 81,691 |
| Income Tax | 18,263 |
| Net Income Continuous | 63,428 |
| Net Income | $63,551 |
| EPS Basic Total Ops | 0.24 |
| EPS Basic Continuous Ops | 0.24 |
| EPS Diluted Total Ops | 0.23 |
| EPS Diluted Continuous Ops | 0.23 |
| EBITDA(a) | $96,252 |